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Osteoarthritis (OA) is a degenerative joint disease 
characterized by the erosion of cartilage joints, 
hypertrophy of the marginal bone, subchondral 
sclerosis, and the morphological and biochemical 
changes of synovial membrane and joint capsule. 
This clinical syndrome is characterized by joint 
pain caused by degeneration of the joints. It is the 
most common joint disease to affl ict the elderly and 
it occurs more often with age.1–3
Erosive osteoarthritis is a subset of OA in 
which there is a destruction of the joints as a 
result of infl ammation.3,4 Changes mainly occur on 
the distal interphalangeal (DIP) joints, proximal 
interphalangeal (PIP) joints, carpometacarpal 
(CMC) joints, and very rarely occur on other joints 
of hand or of other body parts.3–5
The diagnosis is in accordance with the criteria 
of American College of Rheumatology (ACR) 
for OA and is supported by the existence of bone 
erosion on the radiological image. The management 
of this disease is merely for palliative purpose.3,5,6
 
CASE REPORT
A 54-year-old male, works as a teacher, complained 
of having swollen fi ngers and pain at the tips of his 
fi ngers for eight years. The intensity of pain was 
increasing, especially when being pressurized. The 
patient rarely complained of stiffness in his hand. 
These symptoms did not show up on the joints of 
any other body parts. There was no fever or skin 
lesion. Bending motion could be done without any 
diffi culty. He had been on medication but without 
any signifi cant improvement. The patient claimed 
to never have suffered any serious illnesses i.e. 
diabetes mellitus, hypertension, tuberculosis, and 
high uric acid level. There was also no family 
history for those illnesses.
The result of physical examination fi nds the 
patient in good general condition, compos mentis. 
Blood pressure was 120/70 mmHg, pulse was 80 
beats/minute, and he was afebrile. General physical 
examinations were normal. He had normal gait and 
normal extremities except on hand (fi gure 1). On 
local status, there were fi ndings of Heberden’s nodes 
on left and right DIP II–V joints with tenderness 
and deviation toward radial of left DIP IV and right 
DIP V joints. The pain was measured with visual 
analog scale and gave the score of 5.
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Figure 1   Patient’s hand.
Some of the tests conducted, such as pelvic 
rock sign, lateral compression, single leg raised, 
Patrick’s test, and Schober’s test showed negative 
results.
Laboratory examination showed: hemoglobin 
13.5 g/dL, leukocyte count 8.9 × 103/mm3, platelet 
count 286 × 103/mm3, erythrocyte sedimentation 
rate 35 mm/hr, high-sensitivity C-reactive protein 
(hs-CRP) 2.070 mg/L (normal value <10.000 mg/
L), negative rheumatoid factor, negative anti-cyclic 
citrullinated peptide, uric acid 6.3 mg/dL, aspartate 
aminotransferase 38 IU/L, alanine aminotransferase 
17 IU/L, total cholesterol 195 mg/dL, triglyceride 
97 mg/dL, high-density lipoprotein cholesterol 38 
mg/dL, low-density lipoprotein cholesterol 130 
mg/dL, ureum 19 mg/dL, creatinine 1.2 mg/dL, 
albumin 3.6 g/dL, and globulin 3.2 g/dL. Urinalysis 
test showed negative on protein and glucose, and 
microscopic examination was within normal limit. 
Radiological examination showed no 
abnormalities on the chest X-ray. Pelvic X-ray was 
also normal along with its sacroiliac joint. Hand X-
ray (fi gure 2) showed luxatio of right DIP IV and left 
DIP V joints, juxta-articular porosis, and sclerosis 
of distal of medial phalanx and proximal of distal 
phalanx of fi ngers II-V of both hands along with the 
narrowing of DIP joints of both hands. There was 
no calcifi cation. Impression is in accordance with 
the image of bilateral hand rheumatoid arthritis.
Based on the history along with physical and 
laboratory examinations, the patient was diagnosed 
with erosive OA and treated with methotrexate 5 
mg/week, folic acid 1 mg q.d, 50 mg diclofenac 
sodium b.i.d, and omeprazole 20 mg q.d.
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Figure 2   Hand X-ray.
DISCUSSION
Osteoarthritis is the most common form of arthritis, 
characterized by a slowly progressive degeneration of cartilage 
joints. Its main predilection is the weight bearing joints. It 
has a greater prevalence among women and its incidence is 
increasing with age.1,3–5  This is the case of 54-year-old male 
with the symptoms which had been felt on both hands for 
eight years.
Symptoms commonly felt by patients with OA are joint 
pains, morning stiffness, or stiffness after resting, usually lasts 
for less than 30 minutes.3,5 American College of Rheumatology 
has developed a diagnostic criteria for hand OA as follows: 
(1) pain, aching, or stiffness in the hand; (2) hard tissue 
enlargement of two or more of 10 hand joints; (3) less than 
three swollen MCP joints; (4) hard tissue enlargement of two 
or more DIP joints; or (5) deformity of two or more of 10 hand 
joints. Diagnosis is confi rmed by the presence of (1), (2), (3) 
and (4) or (1), (2), (3) and (5) or (1) plus 3 from (2)–(5). The 
10 hand joints referred above are the DIP II & III, PIP II & III, 
and CMC. By these criteria the sensitivity and specifi city for 
diagnosing hand OA is 92% and 98%.5 This case met all the 
criteria.
There are several subsets of osteoarthritis: primary 
and secondary, local and generalized, hypertrophic and 
atrophic, infl ammatory or noninfl ammatory, with and without 
chondrocalcinosis or calcium phosphate crystal deposition, 
and rapidly progressive.7 Erosive OA is a primary OA with 
a more severe infl ammation, bone abnormality (erosion), and 
ankylosis in some cases. Kellgren and Moore was the fi rst to 
describe this condition in 1952. At fi rst, the term infl ammatory 
OA was used to emphasize the commonly encountered clinical 
symptom, i.e. the infl ammatory process, but now the more 
commonly used term is erosive OA.8–11
Erosive OA is a rare type of OA. It is found commonly on 
postmenopausal women. Genetic factors also play role: HLA 
DR2 is a suspected risk factor for erosive OA.8,11,12 Erosive 
OA began with a sudden pain accompanied by stiffness in 
the morning of the DIP joints, which then spreads to the PIP 
joints, commonly symmetrical, while regular OA is usually 
slow and generalized. It rarely affl icts foot joints or any other 
large joints.3,8,9 Laboratory fi ndings are generally nonspecifi c 
although there are reports of a higher CRP level in erosive 
OA than in a regular OA.8,9,13 This case occurred in a 54-
year-old male and affl icted the DIP joints II-V on both hands. 
Laboratory results were within normal limits.
Radiological fi nding of erosive OA are periarticular 
osteoporosis and subchondral erosion. In contrast to the 
erosion of rheumatoid arthritis that occurs in the marginal, 
erosion in erosive OA occurs in the central, accompanied by 
marginal proliferation resulting in a “gull-wing” appearance. 
In psoriatic arthritis, marginal erosion also occurs along with 
marginal periostitis. The patient’s hand X-ray showed evidence 
of bone erosion and juxta-articular osteoporosis.3,8
Differential diagnoses of erosive OA are rheumatoid 
arthritis and psoriatic arthritis. This case had similar 
radiological image with rheumatoid arthritis but affl icts the 
DIP joints and showed neither symptoms nor signs supporting 
the diagnosis of rheumatoid arthritis or psoriatic arthritis.3
Currently there are no standard treatments for erosive OA 
so that the fi rst treatment recommended is similar to those of 
regular OA, pharmacological and non pharmacological. The 
recommended pharmacological therapy is simple analgesics, 
nonsteroidal anti-infl ammatory drugs, and intra-articular 
and topical steroid.5,6 For cases less responsive to standard 
therapy, it can be considered administering methotrexate, 
hydroxychloroquine, or anti-TNFα. Several studies have 
reported satisfactory result with these drugs.10,14,15 The patient 
in this case was given doses of methotrexate 5 mg/week, 
folic acid 1 tabet q.d., diclofenac sodium 50 mg b.i.d., and 
omeprazole 20 mg q.d.
SUMMARY
We reported a case of erosive osteoarthritis, which is a subset 
of OA. The diagnosis of hand OA is based on ACR criteria and 
supported by the radiological image in the form of subchondral 
erosion and juxta-articular osteoporosis. There are currently 
no standard treatments for erosive OA, and this patient was 
administered with doses of  methotrexate, diclofenac sodium, 
folic acid, and omeprazole.
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